These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36983680)

  • 1. Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor.
    Ran P; Tan T; Zhou H; Li J; Yang H; Li J; Zhang J
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables.
    Li S; Chen D; Li S; Zhao Z; Yang H; Wang D; Zhang Z; Fu W
    Front Oncol; 2020; 10():581855. PubMed ID: 33585198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
    Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
    Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and external validation of a nomogram for individualized adjuvant imatinib duration for high-risk gastrointestinal stromal tumors: A multicenter retrospective cohort study.
    Liu R; Wu Y; Gong J; Zhao R; Li L; Wan Q; Lian N; Shen X; Xia L; Shen Y; Xiao H; Wu X; Chen Y; Cen Y; Xu X
    Cancer Med; 2022 Aug; 11(16):3093-3105. PubMed ID: 35297216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.
    Gold JS; Gönen M; Gutiérrez A; Broto JM; García-del-Muro X; Smyrk TC; Maki RG; Singer S; Brennan MF; Antonescu CR; Donohue JH; DeMatteo RP
    Lancet Oncol; 2009 Nov; 10(11):1045-52. PubMed ID: 19793678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor.
    Liu X; Lin E; Sun Y; Liu X; Li Z; Jiao X; Li Y; Guo D; Zhang P; Feng X; Chen T; Niu Z; Zhou Z; Qiu H; Zhou Y
    Front Med (Lausanne); 2022; 9():777181. PubMed ID: 35360729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developed and validated a prognostic nomogram for recurrence-free survival after complete surgical resection of local primary gastrointestinal stromal tumors based on deep learning.
    Chen T; Liu S; Li Y; Feng X; Xiong W; Zhao X; Yang Y; Zhang C; Hu Y; Chen H; Lin T; Zhao M; Liu H; Yu J; Xu Y; Zhang Y; Li G
    EBioMedicine; 2019 Jan; 39():272-279. PubMed ID: 30587460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen.
    Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C
    Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients.
    Chok AY; Goh BK; Koh YX; Lye WK; Allen JC; Quek R; Teo MC; Chow PK; Ong HS; Chung AY; Wong WK
    Ann Surg Oncol; 2015 Oct; 22(11):3597-605. PubMed ID: 25652053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen/Albumin Ratio Index Is an Independent Prognosis Predictor of Recurrence-Free Survival in Patients After Surgical Resection of Gastrointestinal Stromal Tumors.
    Cao X; Cui J; Yu T; Li Z; Zhao G
    Front Oncol; 2020; 10():1459. PubMed ID: 33014783
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts.
    Lin Y; Wang M; Jia J; Wan W; Wang T; Yang W; Li C; Chen X; Cao H; Zhang P; Tao K
    EBioMedicine; 2020 Oct; 60():103016. PubMed ID: 32980695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study.
    Bertsimas D; Margonis GA; Tang S; Koulouras A; Antonescu CR; Brennan MF; Martin-Broto J; Rutkowski P; Stasinos G; Wang J; Pikoulis E; Bylina E; Sobczuk P; Gutierrez A; Jadeja B; Tap WD; Chi P; Singer S
    EClinicalMedicine; 2023 Oct; 64():102200. PubMed ID: 37731933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis.
    Tanimine N; Tanabe K; Suzuki T; Tokumoto N; Ohdan H
    World J Surg Oncol; 2012 Feb; 10():43. PubMed ID: 22348408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study.
    Chen T; Ye LY; Feng XY; Qiu HB; Zhang P; Luo YX; Yuan LY; Chen XH; Hu YF; Liu H; Li Y; Tao KX; Yu J; Li GX
    World J Gastroenterol; 2019 Mar; 25(10):1238-1247. PubMed ID: 30886506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
    Qu WZ; Wang L; Chen JJ; Wang Y
    World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Nomogram for Gastrointestinal Stromal Tumors after Surgery Based on the SEER Database.
    Sun Q; Chen Y; Li T; Zhu X; Zhu G; Ni B; Gao R; Li J
    Biomed Res Int; 2022; 2022():5639174. PubMed ID: 36420093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram to predict disease-free survival after surgical resection of GIST.
    Bischof DA; Kim Y; Behman R; Karanicolas PJ; Quereshy FA; Blazer DG; Maithel SK; Gamblin TC; Bauer TW; Pawlik TM
    J Gastrointest Surg; 2014 Dec; 18(12):2123-9. PubMed ID: 25245766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors.
    Ren C; Wang S; Zhang S
    Cancer Imaging; 2020 Jan; 20(1):5. PubMed ID: 31931874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors.
    Lu G; Li J; Wu L; Shi Y; Zhang X; Xia Y; Li L
    Dig Dis; 2022; 40(1):50-61. PubMed ID: 33752202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of recurrence-free survival and adjuvant therapy benefit in patients with gastrointestinal stromal tumors based on radiomics features.
    Wang FH; Zheng HL; Li JT; Li P; Zheng CH; Chen QY; Huang CM; Xie JW
    Radiol Med; 2022 Oct; 127(10):1085-1097. PubMed ID: 36057930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.